Skip to Content
Merck
  • Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant.

Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant.

Journal of pediatric gastroenterology and nutrition (2005-09-01)
Ulla Hoppu, Minna Rinne, Anna-Maija Lampi, Erika Isolauri
ABSTRACT

Breast milk fatty acids may have immunomodulatory properties related to the development of atopic disease. The aim of this study was to assess the impact of the breast milk fatty acid composition on the development of atopic dermatitis (AD) in high-risk infants. Mothers with atopic disease were recruited at the end of gestation. Maternal food records and breast milk samples were collected at the infants' age of one month. Infants were clinically examined and AD diagnosed at one, three, six, and 12 months. Altogether 13 of 34 (38%) infants were diagnosed with AD during the first year of life. Infants developing AD had consumed breast milk with a higher ratio of saturated to polyunsaturated fatty acids and less n-3 fatty acids compared to infants not developing AD. Specifically, breast milk consumed by infants with AD contained more stearic acid, 8.9% of total fatty acids (95% confidence interval 7.9-10.0) in comparison to those without AD, 7.1% (95% CI 6.6-7.7). Breast milk rich in saturated and low in n-3 fatty acids may be a risk factor for atopic dermatitis in the infant.

MATERIALS
Product Number
Brand
Product Description

Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Stearic acid, SAJ first grade, ≥90.0%, powder
Supelco
Stearic acid, analytical standard
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Stearic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Stearic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland